Flare Capital Partners
VC Fund
Boston, United States
Flare Capital Partners is a VC fund in Boston focused on Health Care and Medical. Flare Capital Partners provides capital for early-stage and emerging healthcare technology companies. The firm invests across the United States, recognizing that healthcare technology innovation is occurring in many cities around the country.
- Total investments:
- 126
- Last investment:
- Lead investor:
- 36%
- Fund size:
- $350M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Flare Capital Partners invests in
Stages Flare Capital Partners invests in
Countries Flare Capital Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 13 contacts → | |||
Round size
- Seed
- $2.4M–$10M
- Series A
- $10M–$30M
- Series B
- $10M–$125M
Investment Focus
Industry
- Health Care 65 (52%)
- Medical 17 (13%)
- Wellness 15 (12%)
- Information Technology 12 (10%)
- Software 11 (9%)
Stage
- Series A 30 (24%)
- Seed 28 (22%)
- Series B 19 (15%)
- Series C 14 (11%)
- Series D 7 (6%)
Country
- United States 69 (55%)
- India 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Graham Gardner
Executive Partner
|
Executive Partner | Total investments: 5 | Find email | |
Thomas MacMahon
Executive Partner
|
Executive Partner | Total investments: 2 | Find email | |
Adam Bruce
Chief Financial Officer and Partner
|
Chief Financial Officer and Partner | Total investments: 0 | Find email | |
Bill Geary
Executive Partner Advisor
|
Executive Partner Advisor | Total investments: 24 | Find email | |
|
Carter Prince
Flare Scholar
|
Flare Scholar | Total investments: 1 | Find email | |
| See all 13 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Kairon Health offers an AI-driven platform to optimize healthcare practice operations and improve workflow efficiency. | $5M / Seed / Sep 15, 2026 | ||
| GenHealth.ai provides healthcare solutions using generative AI trained on encoded medical events. Its product is a generative healthcare AI publicly available. It includes a foundation transformer model (new neural networks with excellent memory), an API, and user applications that can generate and predict future sequences of health events usinghistorical events. Together they can be used to build a large variety of customized applications. | $16.5M / Series A / Sep 08, 2026 | ||
| Onos' AI platform empowers health plans to discern care quality, take meaningful action, and bend the value curve. | $17M / Series A / Aug 26, 2026 | ||
| Inner Logic serves as the development infrastructure for the next generation of procedural devices, including orthopedic implants, heart valves, and surgical robots. | $11.5M / Seed / Jul 22, 2026 | ||
| Upside is the only nationally scalable housing stability platform purpose-built for healthcare. The company partners with health plans and employers to identify and stabilize members and employees experiencing housing instability, connecting them to safe, supportive housing while reducing avoidable emergency utilization and improving healthoutcomes. Upside pairs dedicated Care Guides with AI-supported housing orchestration to deliver measurable results at scale. The platform serves Medicaid, Medicare Advantage, D-SNP, commercial, and employer-sponsored populations across the full housing continuum, from crisis intervention to long-term tenancy support. Founded in 2020 and headquartered in Fort Lauderdale, FL, Upside is redefining how healthcare addresses housing as a foundation of care. | $20M / Series A / Jun 25, 2026 | ||
| A modern prescription network | $16M / Series A / Apr 30, 2026 | ||
| Greatly Health provides virtual integrative oncology programs for people living with and beyond cancer. The company offers access to integrative medicine approaches that are designed to complement conventional cancer care. Its services focus on areas such as exercise, nutrition, and mind-body practices delivered through an online platform. GreatlyHealth connects members with structured, evidence-informed programs that aim to help manage treatment side effects and support overall well-being. The platform serves patients, survivors, and caregivers seeking integrative support alongside their oncology care. Greatly Health does not itself deliver medical services and encourages users to maintain care with their existing clinical providers. | $4M / Seed / Apr 30, 2026 | ||
| AI-Enabled Coding for Medical Billing Teams | $16M / Series A / Apr 15, 2026 | ||
| Qualified Health is a reliable partner for safely utilizing generative AI in medicine. Qualified Health's infrastructure solution offers safeguards for ongoing algorithm performance monitoring, active AI governance, and developing agents tailored to the healthcare industry. Qualified Health are revolutionizing healthcare in America with tophealth system partners. | $125M / Series B / Mar 25, 2026 | ||
| Daffodil Health is a paediatric behavioural health platform that offers multi-modal therapies and real-time support to special needs children and families. | $16.3M / Series A / Feb 17, 2026 | ||
| See all 126 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Flare Capital Partners invest in?
Flare Capital Partners invests primarily in Health Care, Medical and Wellness startups, most often at Series A and Seed stage. Most of the 126 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Flare Capital Partners's check size?
Flare Capital Partners typically joins rounds of $2.4M–$10M at Seed, $10M–$30M at Series A and $10M–$125M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Flare Capital Partners participates in.
How do I contact Flare Capital Partners?
Public channels for Flare Capital Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Flare Capital Partners?
The team at Flare Capital Partners includes Graham Gardner (Executive Partner), Thomas MacMahon (Executive Partner) and Adam Bruce (Chief Financial Officer and Partner), among 13 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
